Here's the live share price of Raymed Labs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Raymed Labs has gained 30.62% CAGR. Over the past year, the corresponding return has been 39.31%.
Raymed Labs’s current P/E of -5.40x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Raymed Labs | 0 | 0 | 4.89 | 15.14 | 39.31 | 32.76 | 30.62 |
Sun Pharmaceutical Industries | 1.70 | 0.56 | -1.22 | -6.08 | -11.89 | 21.53 | 26.69 |
Divi's Laboratories | 1.26 | 1.62 | -7.39 | 4.79 | 11.96 | 18.86 | 14.07 |
Cipla | -1.87 | -0.09 | 2.93 | 2.07 | -5.80 | 12.27 | 15.00 |
Torrent Pharmaceuticals | 2.43 | -0.27 | 15.28 | 13.10 | 5.52 | 34.19 | 21.99 |
Dr. Reddy's Laboratories | -0.73 | 4.92 | -1.40 | 10.13 | -0.28 | 15.72 | 4.92 |
Mankind Pharma | 0.86 | 3.85 | 13.67 | 15.85 | 2.15 | 22.25 | 12.81 |
Zydus Lifesciences | -0.56 | 5.69 | 8.57 | 13.34 | -1.55 | 40.99 | 21.27 |
Lupin | -1.41 | 3.78 | 3.44 | -3.40 | -6.43 | 44.22 | 14.11 |
Alkem Laboratories | 1.00 | 1.95 | 15.16 | 12.21 | -9.63 | 18.36 | 13.94 |
Aurobindo Pharma | 2.07 | 6.82 | 1.92 | -4.86 | -25.36 | 27.94 | 7.15 |
Abbott India | -1.50 | -6.49 | -3.26 | 1.06 | 8.09 | 18.96 | 13.93 |
Glenmark Pharmaceuticals | -4.73 | 5.57 | 24.01 | 37.33 | 24.89 | 74.54 | 33.81 |
Laurus Labs | 0.72 | 3.03 | 38.56 | 49.34 | 93.09 | 19.59 | 25.89 |
Biocon | -1.30 | 0.28 | 2.49 | 5.67 | -1.44 | 6.50 | -3.42 |
Anthem Biosciences | 1.01 | 0.09 | 15.25 | 15.25 | 15.25 | 4.85 | 2.88 |
GlaxoSmithKline Pharmaceuticals | -0.91 | -1.28 | -14.21 | -3.88 | 1.43 | 25.23 | 10.17 |
Ipca Laboratories | 6.02 | 1.82 | 1.54 | -0.48 | -2.78 | 16.97 | 6.00 |
Cohance Lifesciences | -8.71 | 0.24 | -9.07 | -24.97 | -26.23 | 24.71 | 18.79 |
Gland Pharma | -1.03 | 2.89 | 16.17 | 25.82 | 11.38 | -3.51 | 1.90 |
Over the last one year, Raymed Labs has gained 39.31% compared to peers like Sun Pharmaceutical Industries (-11.89%), Divi's Laboratories (11.96%), Cipla (-5.80%). From a 5 year perspective, Raymed Labs has outperformed peers relative to Sun Pharmaceutical Industries (26.69%) and Divi's Laboratories (14.07%).
Day | SMA | EMA |
---|---|---|
5 | 3.58 | 3.59 |
10 | 3.52 | 3.47 |
20 | 3.17 | 3.22 |
50 | 2.68 | 2.77 |
100 | 2.19 | 2.42 |
200 | 2.02 | 2.48 |
In the latest quarter, Raymed Labs remained same as its previous close in promoter holding, while DII stake unchanged at 0.96%, FII holding unchanged at 0.00%, and public shareholding unchanged at 66.78% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 03, 2025, 11:57 PM IST | Raymed Labs Limi - Reg. 34 (1) Annual Report. |
Sep 03, 2025, 11:50 PM IST | Raymed Labs Limi - Fixes Book Closure For The 33Rd Annual General Meeting |
Sep 03, 2025, 11:48 PM IST | Raymed Labs Limi - Intimation Of 33Rd Annual General Meeting To Be Held On Monday, 29Th September, 2025 |
Aug 12, 2025, 9:52 PM IST | Raymed Labs Limi - Board Meeting Outcome for Meeting Held On 12Th August, 2025 |
Aug 07, 2025, 9:47 PM IST | Raymed Labs Limi - Board Meeting Intimation for Meeting Schedule On 12Th August, 2025 |
Raymed Labs Ltd. is a Public Limited Listed company incorporated on 30/03/1992 and has its registered office in the State of Uttar Pradesh, India. Company's Corporate Identification Number(CIN) is L24111UP1992PLC014240 and registration number is 014240. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 4.27 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Raymed Labs is ₹3.65 as on Sep 15, 2025.
The Raymed Labs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Raymed Labs is ₹1.56 Cr as on Sep 15, 2025.
Today’s highest and lowest price of Raymed Labs are ₹3.65 and ₹3.65.
The 52-week high/low is the highest and lowest price at which Raymed Labs stock has traded in the past 52-week or nearly a year. The 52-week high of Raymed Labs is ₹3.65 and 52-week low of Raymed Labs is ₹2.62 as on Sep 15, 2025.
The Raymed Labs has shown returns of 0.0% over the past day, 0.0% for the past month, 4.89% over 3 months, 39.31% over 1 year, 32.76% across 3 years, and 30.62% over 5 years.
P/E ratio of and PB ratio of Raymed Labs are -5.40 and -0.60 on Sep 15, 2025. While the company gives a dividend yield of 0.00 per annum.